Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 465 entries
View as:

A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria

Phase: N/A Priority: Normal
NCT ID: NCT00257140 Org: User:
Start: 06/30/31 End: 07/31/94 Due: 07/31/95

JNJ-41443532 Sex, Race, and Age Pharmacokinetic (PK) Study

Phase: N/A Priority: Normal
NCT ID: NCT01105780 Org: User:
Start: 05/31/10 End: 08/31/10 Due: 08/31/11

Doripenem in the Treatment of Complicated Intra-Abdominal Infections

Phase: N/A Priority: Normal
NCT ID: NCT00229060 Org: User:
Start: 03/31/04 End: 03/31/06 Due: 03/31/07

A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville

Phase: N/A Priority: Normal
NCT ID: NCT00790777 Org: User:
Start: 03/31/07 End: 05/31/07 Due: 05/31/08

Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005648 Org: User:
Start: 11/30/99 End: 11/30/03 Due: 11/30/04

A Study to Determine the Safety of Epoetin Alfa and Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients After Major Orthopedic Surgery.

Phase: N/A Priority: Normal
NCT ID: NCT00270036 Org: User:
Start: 04/30/91 End: 10/31/91 Due: 10/31/92

A Bioequivalence Study of 15 mg ER OROS Paliperidone

Phase: N/A Priority: Normal
NCT ID: NCT00892489 Org: User:
Start: 07/31/04 End: 12/31/04 Due: 12/31/05

A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa

Phase: N/A Priority: Normal
NCT ID: NCT00211068 Org: User:
Start: 03/31/04 End: 03/31/06 Due: 03/31/07

A Study to Observe the Causes and Treatment of Anemia in Critically Ill Children

Phase: N/A Priority: Normal
NCT ID: NCT00211055 Org: User:
Start: 09/30/04 End: 03/31/05 Due: 03/31/06

A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin IR Tablets (2 x 1,000 mg) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01454622 Org: User:
Start: 09/30/11 End: 11/30/11 Due: 11/30/12

A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia.

Phase: N/A Priority: Normal
NCT ID: NCT00086320 Org: User:
Start: 03/31/04 End: 08/31/05 Due: 08/31/06

A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity

Phase: N/A Priority: Normal
NCT ID: NCT00231608 Org: User:
Start: 12/31/98 End: 01/31/02 Due: 01/31/03

A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IR

Phase: N/A Priority: Normal
NCT ID: NCT00791193 Org: User:
Start: 03/31/07 End: 05/31/07 Due: 05/31/08

A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose

Phase: N/A Priority: Normal
NCT ID: NCT00796029 Org: User:
Start: 07/31/03 End: 07/31/03 Due: 07/31/04

A Phase 1 Bioavailability Study of Topiramate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00701493 Org: User:
Start: 11/30/04 End: 12/31/04 Due: 12/31/05

A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00253201 Org: User:
Start: - End: 10/31/97 Due: 10/31/98

A Study of the Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00892125 Org: User:
Start: 09/30/06 End: 03/31/07 Due: 03/31/08

An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00524043 Org: User:
Start: 09/30/07 End: 11/30/08 Due: 11/30/09

A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT00236613 Org: User:
Start: 09/30/00 End: 07/31/01 Due: 07/31/02

A Drug Interaction Study of 31001074 and Paroxetine in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01159821 Org: User:
Start: 08/31/10 End: 10/31/10 Due: 10/31/11

An Efficacy and Safety Study of 3 Fixed Doses of JNJ-37822681 in Participants With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00728195 Org: User:
Start: 11/30/08 End: 02/28/10 Due: 02/28/11

Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00589914 Org: User:
Start: 03/31/07 End: 06/30/09 Due: 06/30/10

A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00119756 Org: User:
Start: 06/30/05 End: 11/30/06 Due: 11/30/07

A Study of the Dose Proportionality of Extended Release Paliperidone

Phase: N/A Priority: Normal
NCT ID: NCT00791167 Org: User:
Start: 06/30/06 End: 08/31/06 Due: 08/31/07

A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations

Phase: N/A Priority: Normal
NCT ID: NCT00796640 Org: User:
Start: 09/30/03 End: 11/30/03 Due: 11/30/04